Literature DB >> 7289007

Toxic shock syndrome. Evidence of a broad clinical spectrum.

R W Tofte, D N Williams.   

Abstract

We evaluated various clinical and laboratory manifestations of toxic shock syndrome (TSS) in 17 menstruating females to define the spectrum of illness. Ten women had definite TSS, while seven who satisfied modified case definition criteria had probable TSS. Patients with definite TSS were younger, and symptoms developed later after onset of menstruation than in those with probable TSS. Overall, 16 (94%) had a rash with subsequent desquamation; 15 (88%), myalgias and orthostatic dizziness; 11 (79%), temperature of 38.9 degrees C or higher; 13 (76%), vomiting; 11 (65%), diarrhea; and 7 (54%), hypotension. All patients survived, and acute respiratory or oliguric renal failure possibly related to the absence of shock did not develop in any of them. None had a recurrent episode of TSS after treatment with an antistaphylococcal antibiotic, discontinuing tampon use, or both. Early recognition and treatment of less severely ill women may obviate potentially serious or fatal recurrences of TSS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7289007     DOI: 10.1001/jama.246.19.2163

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

Review 1.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  An unusual systemic staphylococcal illness with features of the mucocutaneous lymph node syndrome.

Authors:  K S Servilla; J A Green; H J Williams; J J Zone
Journal:  West J Med       Date:  1985-02

Review 3.  Toxic shock syndrome: a review of the literature.

Authors:  D Thomas; P S Withington
Journal:  Ann R Coll Surg Engl       Date:  1985-05       Impact factor: 1.891

4.  Studies on staphylococci from toxic shock syndrome in France, 1981-1983.

Authors:  A K Melconian; J Fleurette; Y Brun
Journal:  J Hyg (Lond)       Date:  1985-02

5.  RS3PE syndrome developing during the course of probable toxic shock syndrome: a case report.

Authors:  Moe Kyotani; Tsuneaki Kenzaka; Ryo Nishio; Hozuka Akita
Journal:  BMC Infect Dis       Date:  2018-04-13       Impact factor: 3.090

6.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.

Authors:  Leora R Feldstein; Erica B Rose; Steven M Horwitz; Jennifer P Collins; Margaret M Newhams; Mary Beth F Son; Jane W Newburger; Lawrence C Kleinman; Sabrina M Heidemann; Amarilis A Martin; Aalok R Singh; Simon Li; Keiko M Tarquinio; Preeti Jaggi; Matthew E Oster; Sheemon P Zackai; Jennifer Gillen; Adam J Ratner; Rowan F Walsh; Julie C Fitzgerald; Michael A Keenaghan; Hussam Alharash; Sule Doymaz; Katharine N Clouser; John S Giuliano; Anjali Gupta; Robert M Parker; Aline B Maddux; Vinod Havalad; Stacy Ramsingh; Hulya Bukulmez; Tamara T Bradford; Lincoln S Smith; Mark W Tenforde; Christopher L Carroll; Becky J Riggs; Shira J Gertz; Ariel Daube; Amanda Lansell; Alvaro Coronado Munoz; Charlotte V Hobbs; Kimberly L Marohn; Natasha B Halasa; Manish M Patel; Adrienne G Randolph
Journal:  N Engl J Med       Date:  2020-06-29       Impact factor: 91.245

7.  Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor VBeta2-positive T cells.

Authors:  Yoshio Matsuda; Hidehito Kato; Ritsuko Yamada; Hiroya Okano; Hiroaki Ohta; Ken'ichi Imanishi; Ken Kikuchi; Kyouichi Totsuka; Takehiko Uchiyama
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

8.  Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by methicillin-sensitive Staphylococcus aureus bacteremia with toxic shock syndrome: a case report.

Authors:  Koki Kosami; Tsuneaki Kenzaka; Yuka Sagara; Kensuke Minami; Masami Matsumura
Journal:  BMC Infect Dis       Date:  2016-04-18       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.